Daiichi Sankyo Aims for Cancer Drug Growth
Daiichi Sankyo plans to double oncology revenue by 2030. The Japanese drugmaker aims to be a top 5 global oncology player by 2035.
While seemingly unrelated to travel, advancements in healthcare can indirectly impact your experience in Japan. A strong pharmaceutical sector contributes to the overall health and well-being of the population, potentially affecting the availability of medical services and supplies for tourists.
Daiichi Sankyo's focus on oncology drug development signifies a commitment to innovation and healthcare advancement within Japan. This investment could lead to improved medical infrastructure and access to cutting-edge treatments.
For travelers, this means potentially greater peace of mind knowing that Japan continues to invest in its healthcare system. While you hopefully won't need it, a robust healthcare sector is always a reassuring factor when traveling abroad.
Original source:The Japan Times ↗
More Japan News
Police obtain arrest warrant for man in Hyogo murder case
The man's whereabouts are unknown, a situation prompting the Hyogo Prefectural Police Department to launch an open investigation into the case.
Spearfisher mauled on Great Barrier Reef in Australia's second fatal shark attack in a week
A spearfisher was mauled on the Great Barrier Reef on Sunday in Australia’s second fatal shark attack in just over a week, police said. The 39-year-old man was…
Used chopsticks upgraded from “waste” to “valuable material” by Kawasaki City thanks to ChopValue
They’re very good at using chopsticks. Every day, millions of people in Japan crack open a bento or dig into a restaurant’s meal while holding a pair of chopsticks that are destined for the garbage on